Overview

Dalacin-T Gel Post Approval Study

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Collaborators:
Acronet
Bellsystem24 , Inc.
Mitsubishi Kagaku Bio-Clinical Laboratories, inc
Parexel
SACT INTERNATIONAL Co., LTD.
Sato Pharmaceutical
SATO Pharmaceutical Co., Ltd.
Treatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Nadifloxacin